Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-03 9:19 pm Purchase | 13D | Dianthus Therapeutics, Inc. DNTH | Avidity Partners Management LP | 2,930,250 9.900% | 7,427 (+0.25%) | Filing History |
| 2024-11-14 7:38 pm Purchase | 13G | Oruka Therapeutics Inc. ORKA | Avidity Partners Management LP | 790,926 2.300% | 790,926 (New Position) | Filing History |
| 2024-11-14 7:07 pm Purchase | 13G | SCYNEXIS, Inc. SCYX | Avidity Partners Management LP | 4,177,203 9.900% | 71,993 (+1.75%) | Filing History |
| 2024-11-14 6:14 pm Purchase | 13G | Perspective Therapeutics, Inc. CATX | Avidity Partners Management LP | 3,590,426 5.300% | 3,590,426 (New Position) | Filing History |
| 2024-11-14 6:08 pm Sale | 13G | Caribou Biosciences, Inc. CRBU | Avidity Partners Management LP | 0 0.000% | -6,360,212 (Position Closed) | Filing History |
| 2024-11-14 6:01 pm Sale | 13G | Jasper Therapeutics, Inc. JSPR | Avidity Partners Management LP | 0 0.000% | -760,000 (Position Closed) | Filing History |
| 2024-11-14 5:33 pm Purchase | 13G | Immunic, Inc. IMUX | Avidity Partners Management LP | 8,989,443 9.900% | 90,025 (+1.01%) | Filing History |
| 2024-11-14 5:31 pm Unchanged | 13G | Context Therapeutics Inc. CNTX | Avidity Partners Management LP | 7,776,296 9.900% | 0 (Unchanged) | Filing History |
| 2024-11-14 5:28 pm Purchase | 13G | Syros Pharmaceuticals, Inc. SYRS | Avidity Partners Management LP | 2,857,573 9.900% | 195,367 (+7.34%) | Filing History |
| 2024-11-14 4:22 pm Sale | 13G | Karyopharm Therapeutics Inc. KPTI | Avidity Partners Management LP | 4,741,060 3.700% | -6,447,683 (-57.63%) | Filing History |
| 2024-05-13 10:37 am Purchase | 13G | Context Therapeutics Inc. CNTX | Avidity Partners Management LP | 7,776,296 9.900% | 7,776,296 (New Position) | Filing History |
| 2024-04-09 8:57 pm Purchase | 13G | ARCA biopharma, Inc. ABIO | Avidity Partners Management LP | 83,333 6.900% | 83,333 (New Position) | Filing History |
| 2024-03-27 4:26 pm Purchase | 13G | Jasper Therapeutics, Inc. JSPR | Avidity Partners Management LP | 760,000 5.100% | 760,000 (New Position) | Filing History |
| 2024-02-14 10:33 am Sale | 13G | Karyopharm Therapeutics Inc. KPTI | Avidity Partners Management LP | 11,188,743 9.500% | -192,330 (-1.69%) | Filing History |
| 2024-02-14 06:50 am Sale | 13G | Kezar Life Sciences, Inc. KZR | Avidity Partners Management LP | 502,545 6.900% | -175,695 (-25.90%) | Filing History |
| 2024-02-14 06:44 am Sale | 13G | IDEAYA Biosciences, Inc. IDYA | Avidity Partners Management LP | 1,520,000 2.400% | -2,304,800 (-60.26%) | Filing History |
| 2024-02-14 06:37 am Sale | 13G | Altimmune, Inc. ALT | Avidity Partners Management LP | 0 0.000% | -3,990,000 (Position Closed) | Filing History |
| 2024-02-13 9:44 pm Sale | 13G | Syndax Pharmaceuticals, Inc. SNDX | Avidity Partners Management LP | 3,950,000 4.700% | -2,768,142 (-41.20%) | Filing History |
| 2024-02-13 9:40 pm Sale | 13G | Akero Therapeutics, Inc. AKRO | Avidity Partners Management LP | 235,000 0.400% | -3,590,000 (-93.86%) | Filing History |
| 2024-02-13 9:34 pm Sale | 13G | Fusion Pharmaceuticals Inc. FUSN | Avidity Partners Management LP | 6,500,328 8.100% | -324,122 (-4.75%) | Filing History |